Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
Genes & Development|May 3, 2007
RDH10 is essential for synthesis of embryonic retinoic acid and is required for limb, craniofacial, and organ developmentLisa L Sandell, Brian W Sanderson, Gennadiy Moiseyev, et al.
Bulletin Du Cancer|May 29, 2021
[Place of coordination of complex pathways in oncology by coordinating private nurses]Maxence Bargoin, Philippe Rey, Nadia Maffre, et al.
Hematological Oncology|July 10, 2026
Intensified Rituximab, Methotrexate, Procarbazine, and Cytarabine (R-MPVA) Regimen With Sequential Addition of Etoposide to R-MPV and Ifosfamide to R-AraC for Newly Diagnosed Primary CNS Lymphoma Patients Aged Between 60 and 70 Years: An LOC Network StudyGabriel Antherieu, Edith Julia, Léopoldine Lapierre, et al.
European Journal of Cancer (Oxford, England : 1990)|December 25, 2016
Utility of post-therapy brain surveillance imaging in the detection of primary central nervous system lymphoma relapseGaëlle Fossard, Céline Ferlay, Emmanuelle Nicolas-Virelizier, et al.
Journal of Geriatric Oncology|February 13, 2026
Individualized physical activity program for older adults undergoing chemotherapy for hematologic malignanciesBaptiste Fournier, Chiara Russo, Aurélia Maire, et al.
Oncotarget|November 22, 2017
Infradiaphragmatic Hodgkin lymphoma: a large series of patients staged with PET-CTCédric Rossi, Morgane Mounier, Pauline Brice, et al.
Frontiers in Medicine|March 19, 2025
Detection of potential complications in cancer survivors after chemotherapy and development of a regional care network: the PASCA feasibility studyRomain Buono, Olivia Pérol, Meyssane Djebali, et al.
Leukemia & Lymphoma|November 1, 2021
Rituximab in combination with adapted-dose of ifosfamide and etoposide as salvage treatment in elderly refractory/relapsed diffuse large B-cell lymphoma patients non-candidate for high dose therapy: a retrospective studyGuillaume Aussedat, Delphine Maucort-Boulch, Philippe Rey, et al.
BMJ Open|June 4, 2021
Individualised physical activity programme in patients over 65 years with haematological malignancies (OCAPI): protocol for a single-arm feasibility trialBaptiste Fournier, Emmanuelle Nicolas-Virelizier, Chiara Russo, et al.
Pathology, Research and Practice|May 30, 2018
Multi-laboratory proficiency testing of clinical cancer genomic profiling by next-generation sequencingQing Zhong, Ulrich Wagner, Henriette Kurt, et al.
Pageof 3